Cell Therapy Manufacturing: Time to Move Fast

The more quickly manufacturing and release obstructions can be cleared, the sooner lifesaving treatments can be administered. Read more: ow.ly/bos650RRMMQ

TILs Designed to Meet Solid Tumor Challenges

When asked about the most challenging part of turning TILs into therapies, it is expanding a sample into billions of cells. Read more: ow.ly/jp3I50RRMUx

Tackling Manufacturing Failures for Viral Vectors

A company founded last year is hoping to tackle a major problem in gene therapy—the failure of therapies to reach the marketplace due to production failures. Learn more: ow.ly/h1LY50RRMZr

In Vivo Gene Editing Grants Access to Medical Treasures

Combining gentle editing and targeted delivery allows gene therapy developers to say “open sesame” to otherwise impassable obstacles. Learn more: ow.ly/9M4050RRMIs

Vaccine Developers Leverage mRNA and Other Powerful Technologies

To counter looming threats, innovative companies are developing safer and more effective mRNA vaccines, virus-like particles, and synthetic attenuated vaccines. Learn more: ow.ly/kiLt50RRMAW

Top 10 Best-Selling Cell and Gene Therapies

Ranking cell and gene therapies in terms of revenues shows a fairly stark line between feast and famine. Learn more: ow.ly/JiVq50RRLOZ

Protein Microparticles Turn Infusions into Injectables

Elektrofi technology allows large-molecule therapeutics to be administered in the form of hyperconcentrated solutions. Learn more: ow.ly/Mk9q50RRLzK

Top 10 Publicly Owned Gene Editing Therapy Companies

With investments, approvals, and revenues on the rise, gene editing therapy is increasingly able to address delivery and accessibility challenges. Learn more: ow.ly/FFts50S4uyK

Only 5 days left to register for THE STATE OF CRISPR AND GENE EDITING summit!

🗓️June 5th
Hosted by Genetic Engineering & Biotechnology News
Sponsored by @Aldevron, @seqwell, MaxCyte, Inc., & GenScript
Featured Speaker: Prof Alison Van Eenennaam (@BioBeef) (@ucdavis)

Register: ow.ly/jIUI50S0n3T
#CRISPR #GeneEditing #Biotech

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster

Insmed (INSM) shares more than doubled after announcing plans to file for its second drug approval with the FDA later this year. Read more: ow.ly/WvO750S4CV6

Protein May Be Key to Why Regenerative Stem Cell Therapies Lead to Cancer

Researchers have identified a protein called EPHA2 that may be a key in preventing tumorigenesis of PSCs after transplantation. Learn more: ow.ly/acsR50S4pau

Compact Cas Protein Fits into Gene Therapy Virus

This can be a significant breakthrough given prior payload size limits and transfection rate limits

insideprecisionmedicine.com/topics/precisi… via Inside Precision Medicine

Drug-Pricing Strategies to Reduce Financial Burdens of Immunotherapy

Cost-effectiveness analyses can inform biopharma about barriers to access, resulting in pricing-structure changes for targeted drugs. Learn more: ow.ly/Fs0T50S4uqG

SOPHiA Launches Precision Cancer Consortium, with Memorial Sloan Kettering as First Member

SOPHiA GENETICS is launching SOPHiA UNITY, a new global data-driven consortium to advance precision cancer research and medicine. Learn more: ow.ly/42je50S4p91

Cryo-EM Structure Reveals Prime Editing Complex in Multiple States

Cryo-EM elucidates the spatial structure and molecular mechanisms of a “prime editor'— a novel gene-editing tool. Learn more: ow.ly/QEeo50S4p6A

Register now for our virtual summit: THE STATE OF CRISPR AND GENE EDITING!

🗓️ June 5th
🕒 8 am PT, 11 am ET, 17:00 CET
📍 Hosted by Genetic Engineering & Biotechnology News
Sponsored by @Aldevron, @seqwell, @MaxCyte, & GenScript

✨ Register for free: ow.ly/MrJf50S0icY

#CRISPR #GeneEditing #Biotech

A naturally occurring, compact version of a CRISPR-associated protein can fit into the non-pathogenic viruses used to deliver targeted gene therapy into cells, research suggests, overcoming issues of size seen with other, better-known forms. Learn more: ow.ly/J9C550S4jST

Can’t Touch This: ExpressionEdits Raises $13M Seed to Redesign Genes for Peak Protein Production

ExpressionEdits' AI-based intronization technology enables the expression of previously unattainable proteins. Learn more: ow.ly/Z3WP50S4oV1

A new study illuminates the mechanisms behind severe inflammation in asthma. Learn more: ow.ly/cQji50S4jvK

Fungal Pathogens Activate Multiple Death Pathways Upon Exposure to Antifungals

Study shows that a common class of antifungals works by causing fungal pathogens to launch self-destructive cellular pathways. Learn more: ow.ly/NFEy50S40EP